BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2258699)

  • 1. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
    Seya T; Hara T; Matsumoto M; Sugita Y; Akedo H
    J Exp Med; 1990 Dec; 172(6):1673-80. PubMed ID: 2258699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Seya T; Kojima A; Hara T; Hazeki K; Sugita Y; Akedo H
    Immunobiology; 1991 Sep; 183(1-2):115-24. PubMed ID: 1718846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
    Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
    Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.
    Oglesby TJ; Allen CJ; Liszewski MK; White DJ; Atkinson JP
    J Exp Med; 1992 Jun; 175(6):1547-51. PubMed ID: 1588280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
    D'Cruz OJ; Haas GG
    Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines.
    Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L
    Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma.
    Fukuda H; Seya T; Hara T; Matsumoto M; Kinoshita T; Masaoka T
    Immunol Lett; 1991 Aug; 29(3):205-9. PubMed ID: 1722775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
    Bjørge L; Jensen TS; Matre R
    Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
    Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
    J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera.
    Seya T; Hara T; Iwata K; Kuriyama S; Hasegawa T; Nagase Y; Miyagawa S; Matsumoto M; Hatanaka M; Atkinson JP
    Int Immunol; 1995 May; 7(5):727-36. PubMed ID: 7547700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.